67
Participants
Start Date
December 2, 2008
Primary Completion Date
December 31, 2012
Study Completion Date
January 1, 2015
filgrastim
Given subcutaneously
pegfilgrastim
Given subcutaneously
rituximab
Given IV
cyclophosphamide
Given IV
liposome-encapsulated doxorubicin citrate
Given IV
prednisone
Given orally
vincristine sulfate
Given IV
Institut Bergonie, Bordeaux
Lead Sponsor
National Cancer Institute, France
OTHER_GOV
Institut Bergonié
OTHER